iifl-logo

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.

Glenmark Pharmaceuticals Ltd Option Chain

Add as a Preferred Source on Google
2,136.7
(0.58%)
Feb 27, 2026|12:00:00 AM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.
Ol (lots)Call PriceStrike PricePut PriceOl (lots)
3,0000%₹354 0%1,700--
--1,720₹1.25 0%7500%
--1,740₹3 0%4,1250%
--1,760₹1.95 0%11,6250%
--1,780₹3 0%3,0000%
1,5000%₹295.3 0%1,800₹2.9 0%12,3750%
--1,820₹4 0%1,8750%
--1,840₹3.75 0%19,5000%
3750%₹202 0%1,860₹4.2 -7.69%23,2500%
4,5000%₹175 0%1,880--
12,0000%₹170 0%1,900₹6.35 -3.05%70,5000%
1,5000%₹217.95 0%1,920₹7.35 -6.96%11,6250%
--1,940₹36 0%7500%
--1,960₹10.75 -6.92%22,8750%
1,1250%₹118.5 0%1,980--
1,30,5000%₹171.75 3.71%2,000₹14.8 -11.64%1,14,7500%
8,2500%₹164.15 0%2,020₹18.1 -14.01%21,0000%
30,7500%₹143.25 6.34%2,040₹21.95 -10.95%43,5000%
55,5000%₹124.6 5.68%2,060₹26.65 -10.86%58,5000%
22,1250%₹110.7 5.02%2,080₹32.2 -8.91%33,3750%
1,75,8750%₹98.95 8.02%2,100₹38.35 -12.64%87,3750%
33,7500%₹88.3 10.86%2,120₹45.05 -12.43%26,2500%
85,5000%₹73.9 7.25%2,140₹55.35 -8.66%58,8750%
62,2500%₹65.1 8.59%2,160₹64.35 -7.8%23,6250%
28,8750%₹57.45 13.2%2,180--
1,78,5000%₹49 14.08%2,200₹88.35 -7.09%25,5000%
18,0000%₹41.5 15.92%2,220--
46,8750%₹35 14.75%2,240₹169.85 0%2,6250%
20,6250%₹28.9 15.13%2,260₹129.3 -5.03%3,7500%
84,3750%₹23.5 9.81%2,280--
61,1250%₹19.65 8.26%2,300--
93,0000%₹16.75 12.41%2,320₹200.75 0%28,1250%
70,1250%₹11 4.26%2,360--
79,8750%₹8.2 11.56%2,400--

Glenmark Pharma.: Related NEWS

Glenmark Pharma Q3 FY26 Profit Rises 16% to ₹403.2 Crore

Revenue from North America increased 24% year on year to ₹970.6 crore, including income from the out licensing of ISB 2001.

31 Jan 2026|02:22 PM
Read More
Top Stocks for Today - 25th September 2025

Here are some of the stocks that may see significant price movement today: Polycab India, Tata Steel, Dalmia Bharat, etc.

25 Sep 2025|06:57 AM
Read More
Top Stocks for Today - 23rd September 2025

Here are some of the stocks that may see significant price movement today: Glenmark Pharma, Rail Vikas Nigam, Birla Corp, etc.

23 Sep 2025|07:01 AM
Read More
Glenmark subsidiary gets $700 Million in licensing deal; stock gains

At around 2.19 PM, Glenmark Pharma was trading 2.97% higher at ₹2,112.90 per piece, against the previous close of ₹2,051.90 on NSE.

9 Sep 2025|02:31 PM
Read More
Glenmark Pharma Q1 Net Profit Falls 86% YoY to ₹47 Crore

Operating performance was slightly weaker, with EBITDA dipping 1.4% to ₹580 crore from ₹588.2 crore.

18 Aug 2025|01:03 PM
Read More
Top Stocks for Today - 18th August 2025

Here are some of the stocks that may see significant price movement today: Glenmark Pharmaceuticals, Vedanta, Inox Wind, etc.

18 Aug 2025|08:14 AM
Read More
Glenmark Shares Surge 10% After AbbVie Inks Licensing Deal for ISB 2001

The compound is currently in Phase 1B clinical trials, being studied for multiple myeloma, a tough-to-treat form of blood cancer.

11 Jul 2025|09:48 AM
Read More
Top Stocks for Today - 11th July 2025

Here are some of the stocks that may see significant price movement today: Tata Consultancy Services, IREDA, Glenmark Pharma, etc.

11 Jul 2025|07:20 AM
Read More
Top Stocks for Today - 26th May 2025

Here are some of the stocks that may see significant price movement today: Glenmark Pharma, Ashok Leyland, NTPC, etc.

26 May 2025|06:34 AM
Read More
Glenmark Pharma’s cancer drug receive FDA ‘fast track’ status

ISB 2001 is a tri-specific antibody therapeutic for targeting BCMA and CD38 on myeloma cells, as well as CD3 on T cells.

6 May 2025|09:31 AM
Read More
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2026, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund & Specialized Investment Fund Distributor), PFRDA Reg. No. PoP 20092018

ISO certification icon
We are ISO/IEC 27001:2022 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.